<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药事纵横 | wechat-feeds</title><link>http://MzUxOTgxNzg4NA.favicon.privacyhide.com/favicon.ico</link><description>药事纵横是一个由多位制药精英联合创办的媒体平台，旨在分享与传递药品研发、生产和注册中所涉及的技术、经验和情报，欢迎关注和投稿！ 投稿请发：442015666@qq.com 推广合作请联系：15057280775/15858667450</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 20 May 2021 07:26:47 +0800</pubDate><image><url>http://MzUxOTgxNzg4NA.favicon.privacyhide.com/favicon.ico</url><title>药事纵横 | wechat-feeds</title><link>http://MzUxOTgxNzg4NA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>“儿童滥用复方感冒药”，比“肿瘤治疗黑幕事件”更严重</title><link>https://mp.weixin.qq.com/s/WleBnxFd3NcviV-Uj8cKrw</link><description></description><content:encoded><![CDATA[“儿童滥用复方感冒药”，比“肿瘤治疗黑幕事件”更严重]]></content:encoded><pubDate>Wed, 19 May 2021 20:32:32 +0800</pubDate></item><item><title>液相故障排除指南（六）：正相色谱法</title><link>https://mp.weixin.qq.com/s/nW375tI2qGd7067q0NTvhw</link><description></description><content:encoded><![CDATA[液相故障排除指南（六）：正相色谱法]]></content:encoded><pubDate>Wed, 19 May 2021 20:32:32 +0800</pubDate></item><item><title>溶出试验中使用表面活性剂时注意事项</title><link>https://mp.weixin.qq.com/s/DPqefGh6-TGvhwwUmGJx0w</link><description></description><content:encoded><![CDATA[溶出试验中使用表面活性剂时注意事项]]></content:encoded><pubDate>Wed, 19 May 2021 20:32:32 +0800</pubDate></item><item><title>浅析纳米晶技术在新药领域的开发应用</title><link>https://mp.weixin.qq.com/s/IhQR_0JZwF3mnsniyaUcxw</link><description></description><content:encoded><![CDATA[浅析纳米晶技术在新药领域的开发应用]]></content:encoded><pubDate>Tue, 18 May 2021 20:06:29 +0800</pubDate></item><item><title>液相故障排除指南（六）：峰拖尾的原因</title><link>https://mp.weixin.qq.com/s/QUzgtlymXKsy69bv-fvU3g</link><description></description><content:encoded><![CDATA[液相故障排除指南（六）：峰拖尾的原因]]></content:encoded><pubDate>Tue, 18 May 2021 20:06:29 +0800</pubDate></item><item><title>基因毒性杂质判断及限度计算方法</title><link>https://mp.weixin.qq.com/s/o6T4mWM18LaXyBamVlBuVw</link><description></description><content:encoded><![CDATA[基因毒性杂质判断及限度计算方法]]></content:encoded><pubDate>Tue, 18 May 2021 20:06:29 +0800</pubDate></item><item><title>2020上市药企分红top100：前5家豪分百亿</title><link>https://mp.weixin.qq.com/s/Y74_GlUAb6ccyqa4FHEuyQ</link><description></description><content:encoded><![CDATA[2020上市药企分红top100：前5家豪分百亿]]></content:encoded><pubDate>Mon, 17 May 2021 22:06:40 +0800</pubDate></item><item><title>【重磅】中国AI新药合作大会来袭</title><link>https://mp.weixin.qq.com/s/FviuPq-Xea5URX2UFRtjmg</link><description></description><content:encoded><![CDATA[【重磅】中国AI新药合作大会来袭]]></content:encoded><pubDate>Mon, 17 May 2021 22:06:40 +0800</pubDate></item><item><title>十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会</title><link>https://mp.weixin.qq.com/s/XPUJCiadN0ezxpxwVCKF5Q</link><description></description><content:encoded><![CDATA[十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会]]></content:encoded><pubDate>Mon, 17 May 2021 22:06:40 +0800</pubDate></item><item><title>ADC抗体（抗体偶联药物）大热，PDC药物会是下一个风口？</title><link>https://mp.weixin.qq.com/s/mDJLuAQpkR5UZ1P7KhLjGA</link><description></description><content:encoded><![CDATA[ADC抗体（抗体偶联药物）大热，PDC药物会是下一个风口？]]></content:encoded><pubDate>Mon, 17 May 2021 22:06:40 +0800</pubDate></item><item><title>药审中心招聘51名编外人员！</title><link>https://mp.weixin.qq.com/s/Ew8xaeEHnVZTqtjKc7EKwQ</link><description></description><content:encoded><![CDATA[药审中心招聘51名编外人员！]]></content:encoded><pubDate>Mon, 17 May 2021 22:06:40 +0800</pubDate></item><item><title>脱发：正在演变的国民焦虑</title><link>https://mp.weixin.qq.com/s/9d1JCHU1IyFgUOxXBDoLJw</link><description></description><content:encoded><![CDATA[脱发：正在演变的国民焦虑]]></content:encoded><pubDate>Sun, 16 May 2021 18:27:09 +0800</pubDate></item><item><title>液相故障排除指南（五）：样品制备方面的问题</title><link>https://mp.weixin.qq.com/s/fdOrly-CI1PwAncJ7JZM4w</link><description></description><content:encoded><![CDATA[液相故障排除指南（五）：样品制备方面的问题]]></content:encoded><pubDate>Sun, 16 May 2021 18:27:09 +0800</pubDate></item><item><title>API和制剂中诱变性降解杂质的评估策略</title><link>https://mp.weixin.qq.com/s/ScvsVh_mUtjeNffhwxgfvQ</link><description></description><content:encoded><![CDATA[API和制剂中诱变性降解杂质的评估策略]]></content:encoded><pubDate>Sun, 16 May 2021 18:27:09 +0800</pubDate></item><item><title>洛那法尼：从治疗癌症旧药到治疗早衰症新星</title><link>https://mp.weixin.qq.com/s/wspYgaHU0ZSbN4hYOQgt7g</link><description></description><content:encoded><![CDATA[洛那法尼：从治疗癌症旧药到治疗早衰症新星]]></content:encoded><pubDate>Sat, 15 May 2021 21:06:20 +0800</pubDate></item><item><title>【免费参会】中国AI新药合作大会</title><link>https://mp.weixin.qq.com/s/rDMNYHcf5aHJUFSbaJce6w</link><description></description><content:encoded><![CDATA[【免费参会】中国AI新药合作大会]]></content:encoded><pubDate>Sat, 15 May 2021 21:06:20 +0800</pubDate></item><item><title>限免倒计时：大咖云集共话热点 ，这个高端制剂/改良新药峰会火热报名中</title><link>https://mp.weixin.qq.com/s/iQqG5brYcpRnzS34BPYgNg</link><description></description><content:encoded><![CDATA[限免倒计时：大咖云集共话热点 ，这个高端制剂/改良新药峰会火热报名中]]></content:encoded><pubDate>Sat, 15 May 2021 21:06:20 +0800</pubDate></item><item><title>中国新药研发的未来</title><link>https://mp.weixin.qq.com/s/9u0PcM_7pSO9PIjnbSfKNw</link><description></description><content:encoded><![CDATA[中国新药研发的未来]]></content:encoded><pubDate>Sat, 15 May 2021 21:06:20 +0800</pubDate></item><item><title>抗体 | 迈威生物，抗CD47/PD-L1双特异性抗体申报临床；这些企业也在做...</title><link>https://mp.weixin.qq.com/s/WiBhf6-GVshT70sHjKeacA</link><description></description><content:encoded><![CDATA[抗体 | 迈威生物，抗CD47/PD-L1双特异性抗体申报临床；这些企业也在做...]]></content:encoded><pubDate>Sat, 15 May 2021 21:06:20 +0800</pubDate></item><item><title>【免费参会】中国AI新药合作大会</title><link>https://mp.weixin.qq.com/s/dCPyuP98rMiuTdK_3FG8Kw</link><description></description><content:encoded><![CDATA[【免费参会】中国AI新药合作大会]]></content:encoded><pubDate>Fri, 14 May 2021 17:25:48 +0800</pubDate></item></channel></rss>